News and Trends 2 Aug 2022
Enrollment completed for trial looking at treatment of diabetic kidney disease
Enrollment has been completed for a study of a regenerative cell therapy investigational product for intra-renal artery administration to treat diabetic kidney disease (DKD). U.S.-based Caladrius Biosciences Inc., a clinical-stage…